SciELO - Scientific Electronic Library Online

 
vol.12 número1Valor prognóstico da função ventricular avaliada por ecocardiografia com speckle tracking em pacientes com sepseEfeitos de um programa de exercícios em um adulto com acidente vascular encefálico após transplante cardíaco índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Insuficiencia cardíaca

versão On-line ISSN 1852-3862

Resumo

CURSACK¹*, Guillermo et al. Severe right ventricular dysfunction by echocardiography in pulmonary arterial hypertension:: prevalence, clinical predictors, echocardiograph and treatment. Insuf. card. [online]. 2017, vol.12, n.1, pp.16-23. ISSN 1852-3862.

Introduction. Severe right ventricular dysfunction (SRVD) is a high risk marker in patients with pulmonary arterial hypertension (PAH). However, its clinical characteristics in Latin-Americans are poorly known. Objective. We sought to assess the prevalence, clinical markers and treatment of SRVD in Argentinean patients with PAH. Material and methods. Between Jan-10/Dec-11, 422 patients with diagnosis of pulmonary hypertension were prospectively included in 31 centers from 13 provinces from Argentina. Of them, 124 (29.4%) with diagnosis of PAH were included in the present analysis. SRVD was defined by moderate to severe RV dysfunction or TAPSE <15 mm. Results. Mean age was 45±17 and 78% were female. In logistic regression analysis, independent clinical predictors were fatigue (HR=5.2, 95%CI=1.9-14.1, p=0.001), heart rate (HR=1.045, 95%CI=1.003-1.088, p=0.033), and cardiomegaly (HR=2.9, 95%CI=1.2-7.5, p=0,024). Echocardiogram in SRVD showed more frequently right atrial dilation (84 vs 61%, p=0.013), and higher systolic pulmonary artery pressure (89±28 vs 77±27 mmHg, p=0.045), with lower left ventricular ejection fraction (59±12 vs 67±10 %, p=0.002). Treatment in SRVD was different in the use of diuretics (87 vs 63%, p=0.010) and digoxin (38 vs 20%, p=0.031), and it was similar in the use of sildenafil (87 vs 74%); iloprost (11 vs 10%); bosentan (19 vs 9%); treprostinil (5 vs 5%), and ambrisentan (5 vs 5%). Conclusion. One out of three patients with PAH presented SRVD. Physical examination and chest x-ray permit clinical identification. These patients received similar rate of specific drugs, suggesting the need of optimization of therapy driven to PAH in these more severe cases.

Palavras-chave : Arterial pulmonary hypertension; Right ventricular dysfunction; Vascular resistance; Pulmonary circulation; Heart diseases; Argentine.

        · resumo em Português | Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons